NKGen Biotech, Inc. Warrants
NKGNW
NKGNW was delisted on the 4th of March, 2025.
29 hedge funds and large institutions have $159K invested in NKGen Biotech, Inc. Warrants in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
6% less funds holding
Funds holding: 31 → 29 (-2)
29% less capital invested
Capital invested by funds: $224K → $159K (-$64.6K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$4.28K |
| 2 |
SFA
Sequoia Financial Advisors
Akron,
Ohio
|
+$2.77K |
| 3 |
BOCH
Blue Owl Capital Holdings
New York
|
+$2.68K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$98 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$83 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KL
KIM LLC
Wichita,
Kansas
|
-$9.11K |
| 2 |
EAM
Exos Asset Management
New York
|
-$5.18K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$1.89K |
| 4 |
FTUS
Flow Traders U.S.
New York
|
-$260 |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$184 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
UBS Group
Zurich,
Switzerland
| $1.03K | +$83 | +932 | +7% |
|
|
FTUS
27
Flow Traders U.S.
New York
| $1K | -$260 | -2,903 | -19% |
|
|
CL
28
CSS LLC
Chicago,
Illinois
| $905 | – | – | – |
|
|
CCM
29
CAAS Capital Management
New York
| $707 | – | – | – |
|
|
KL
30
KIM LLC
Wichita,
Kansas
| – | -$9.11K | -92,040 | Closed |
|
|
PC
31
Periscope Capital
Toronto,
Ontario, Canada
| – | -$1.89K | -19,110 | Closed |
|
NKGNW Hedge Fund Activity: Q3 2024 in Review
29 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q3 2024, worth a combined $159K — down 29% from $224K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NKGNW and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.
The largest buyer was Cowen and Company, adding an estimated $4.28K. The largest seller was KIM LLC, exiting entirely with an estimated $9.11K sold.
- 29 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q3 2024, down from 31 in Q2 2024.
- Funds reported $159K of NKGen Biotech, Inc. Warrants stock for Q3 2024, down 29% quarter-over-quarter.
- 1 fund opened new NKGen Biotech, Inc. Warrants positions in Q3 2024 and 2 closed out, a net change of -1 holder.
- The largest NKGen Biotech, Inc. Warrants buyer in Q3 2024 was Cowen and Company, an estimated $4.28K added.
- The largest NKGen Biotech, Inc. Warrants seller in Q3 2024 was KIM LLC, an estimated $9.11K sold.
Based on aggregated 13F filings for Q3 2024.